ArticleCancer discovery2016

Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition.

Mary T Scott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.